...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Urinary incontinence in prostate cancer patients treated with external beam radiotherapy.
【24h】

Urinary incontinence in prostate cancer patients treated with external beam radiotherapy.

机译:接受外部束放射治疗的前列腺癌患者的尿失禁。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: To describe the incidence of urinary incontinence among prostate cancer patients treated with external beam radiotherapy (RT) and to investigate associated risk factors. PATIENTS AND METHODS: One thousand and hundred ninety-two patients with >or=24 months follow-up were the subjects of this series. All patients received between 50 and 72 Gy in 20-37 fractions (median 66 Gy/33#). Post-RT urinary incontinence was scored by direct patient interviewing according to the modified RTOG/SOMA scale: Grade 1--occasional use of incontinence pads, Grade 2--intermittent use of incontinence pads, Grade 3--persistent use of incontinence pads, and Grade 4--permanent catheter. Risk-factors investigated were: age, diabetes, TURP prior to RT, elapsed time from TURP to RT, clinical stage, RT dose and presence of Grade >or=2 acute GU and GI toxicity. Non-parametric, actuarial univariated (Kaplan-Meier) and multivariated tests (MVA, Cox regression) were performed. RESULTS: Median follow-up for the group is 52 months (24-109). Thirty-four patients (2.9%) had incontinence prior to RT, which was more common in TURP patients (7.8% vs 1.6% P<0.001). These are excluded from further analysis. Fifty-seven patients (4.9%) developed Grade 1 incontinence, 7 (0.6%) Grade 2, and 7 (0.6%) Grade 3. There was no Grade 4 incontinence. Actuarial rates for Grade >or=1 and >or=2 incontinence at 5 years are 7 and 1.7%, respectively. Risk factors on MVA associated with the development of Grade 1 or worse incontinence are pre-RT TURP (5-year rates 10% vs 6%, P=0.026), presence of Grade >or=2 acute GU toxicity (5-year rates 11% vs 5%, P=0.002). Age, diabetes, clinical stage, elapsed time from TURP to RT, RT dose or fraction size, acute GI toxicity were not significant. Patients who underwent post-RT TURP or dilatation for obstructive symptoms (4.3%), were more likely to develop Grade 2-3 incontinence (5-year rate 8 vs 1.5%, P=0.0015). CONCLUSIONS: Grade 2 or greater urinary incontinence is rare among patients who have been treated with external beam radiotherapy. Associated risk factors are pre-RT TURP and the presence of increased acute GU toxicity. Post-radiaton TURP increases the risk of incontinence five-fold.
机译:背景与目的:描述在接受外照射治疗的前列腺癌患者中尿失禁的发生率,并研究相关的危险因素。患者与方法:109例≥24个月的随访患者是本系列的研究对象。所有患者均以20-37的分数(中位数66 Gy / 33#)接受50至72 Gy。根据改良后的RTOG / SOMA评分标准,通过直接的患者访谈对RT后尿失禁进行评分:1级-偶尔使用失禁垫,2级-间歇使用失禁垫,3级-持续使用失禁垫,和4级永久导管。研究的危险因素为:年龄,糖尿病,放疗前的TURP,从TURP到放疗的经过时间,临床阶段,放疗剂量以及是否存在≥2级的急性GU和GI毒性。进行了非参数,精算单变量(Kaplan-Meier)和多变量检验(MVA,Cox回归)。结果:该组的中位随访时间为52个月(24-109)。三十四名患者(2.9%)在放疗前出现尿失禁,这在TURP患者中更为常见(7.8%vs 1.6%,P <0.001)。这些已从进一步分析中排除。五十七名患者(4.9%)发生了1级失禁,7(0.6%)2级和7(0.6%)3级。没有4级失禁。 5年级尿失禁>或= 1和>或= 2的精算率分别为7和1.7%。与1级或更严重失禁发展相关的MVA的危险因素是RT前TURP(5年率10%比6%,P = 0.026),存在>或= 2级急性GU毒性(5年率) 11%和5%,P = 0.002)。年龄,糖尿病,临床阶段,从TURP到RT的时间,RT剂量或分数大小,急性胃肠道毒性均无统计学意义。接受RT TURP或因阻塞性症状扩张的患者(4.3%)更容易发生2-3级失禁(5年率8 vs 1.5%,P = 0.0015)。结论:接受外部束放射治疗的患者很少发生2级或以上的尿失禁。相关的危险因素是RT前TURP和急性GU毒性增加。放射后TURP将失禁的风险增加了五倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号